2023
DOI: 10.1016/j.jddst.2022.104144
|View full text |Cite
|
Sign up to set email alerts
|

Cladosporium protease/doxorubicin decorated Fe3O4@SiO2 nanocomposite: An efficient nanoparticle for drug delivery and combating breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 107 publications
0
2
0
Order By: Relevance
“…[19] Metal oxide nanocomposites have a general tendency to agglomerate due to their high surface energy and high surface to volume ratio. They often do not have suitable surface properties for specific applications, e. g. oil recovery, [20] removal of toxic ions, [21] antibacterial agents, [22] drug delivery, [23] and removal of toxic dyes. [24] To solve these issues, it is often necessary to modify the surface of metal oxide nanocomposites.…”
Section: Introductionmentioning
confidence: 99%
“…[19] Metal oxide nanocomposites have a general tendency to agglomerate due to their high surface energy and high surface to volume ratio. They often do not have suitable surface properties for specific applications, e. g. oil recovery, [20] removal of toxic ions, [21] antibacterial agents, [22] drug delivery, [23] and removal of toxic dyes. [24] To solve these issues, it is often necessary to modify the surface of metal oxide nanocomposites.…”
Section: Introductionmentioning
confidence: 99%
“…Magnetite nanoparticles (Fe 3 O 4 NPs) have attracted considerable attention in many application areas, including environmental treatment [ 1 , 2 , 3 ], food analysis [ 4 , 5 , 6 ], biosensors [ 7 , 8 ], protein immobilization [ 9 ], targeted drug delivery [ 10 , 11 , 12 , 13 , 14 ], separation [ 15 , 16 , 17 ], magnetic resonance imaging (MRI) [ 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ], magnetofection [ 28 , 29 ], tissue engineering [ 30 ], and hyperthermia [ 31 , 32 ]. In particular, their good biocompatibility, as verified by the U.S. Food and Drug Administration [ 33 ], facilitates their commercialization.…”
Section: Introductionmentioning
confidence: 99%